Associations of N-terminal pro-B-type natriuretic peptide, estimated glomerular filtration rate, and mortality in US adults

被引:5
作者
Ozkan, Bige [1 ,2 ,3 ]
Grams, Morgan E. [4 ]
Coresh, Josef [1 ,2 ]
McEvoy, John W. [5 ,6 ]
Echouffo-Tcheugui, Justin B. [7 ]
Mu, Scott Z. [1 ,2 ]
Tang, Olive [8 ]
Daya, Natalie R. [1 ,2 ]
Kim, Hyunju [1 ,2 ]
Christenson, Robert H. [9 ]
Ndumele, Chiadi E. [3 ]
Selvin, Elizabeth [1 ,2 ,10 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[2] Johns Hopkins Bloomberg Sch Publ Hlth, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD USA
[3] Johns Hopkins Univ, Sch Med, Ciccarone Ctr Prevent Cardiovasc Dis, Baltimore, MD USA
[4] NYU, Grossman Sch Med, Div Precis Med Res, New York, NY USA
[5] Natl Univ Ireland, Div Cardiol, Galway, Ireland
[6] Natl Univ Ireland, Natl Inst Prevent & Cardiovasc Hlth, Galway, Ireland
[7] Johns Hopkins Univ, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Baltimore, MD USA
[8] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[9] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD USA
[10] Bloomberg Sch Publ Hlth, 2024 E Monument St,Suite 2-639, Baltimore, MD 21287 USA
基金
美国国家卫生研究院;
关键词
HEART-FAILURE; CARDIAC BIOMARKERS; KIDNEY-DISEASE; AMERICAN; DYSFUNCTION; PREDICTOR; BNP;
D O I
10.1016/j.ahj.2023.05.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background NT-proBNP is an important predictor of mortality but is inversely related to estimated glomerular filtration rate (eGFR). Whether the prognostic value of NT-proBNP is similar at different levels of kidney function is unknown.Aims We evaluated the association of NT-proBNP with eGFR and its implications for all-cause and cardiovascular mortality risk in the general population.Methods We included adults without prior cardiovascular disease from the National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. We used linear regression to characterize the cross-sectional associations of NT-proBNP with eGFR. We used Cox regression to assess the prospective associations of NT-proBNP with mortality across categories ofResults Among 11,456 participants (mean age 43 years, 48% female, 71% White, 11% Black), there was an inverse association between NT-proBNP and eGFR, which was stronger in those with more impaired kidney function. Per 15-unit decrease in eGFR, NT-proBNP was 4.3-fold higher for eGFR < 30; 1.7-fold higher for eGFR 30 to 60, 1.4-fold higher for eGFR 61 to 90, 1.1-fold higher for eGFR 91 to 120 mL/min/1.73 m 2 . Over a median 17.6 years of follow-up, 2,275 deaths (622 cardiovascular) occurred. Higher NT-proBNP was associated with higher all-cause (HR per doubling of NT-proBNP: 1.20, 95% CI: 1.16-1.25) and cardiovascular mortality (HR: 1.34, 95% CI 1.25-1.44). Associations were similar across eGFR categories ( P -interaction > .10). Adults with NT-proBNP & GE;450 pg/mL and eGFR < 60 mL/min/1.73m 2 had 3.4-fold higher all-cause mortality and 5.5-fold higher cardiovascular mortality risk, compared to those with NT-proBNP < 125 pg/mL andConclusion Despite its strong inverse association with eGFR, NT-proBNP has robust associations with mortality across the full range of kidney function in the general US adult population. (Am Heart J 2023;264:49-58.)
引用
收藏
页码:49 / 58
页数:10
相关论文
共 35 条
  • [1] [Anonymous], 2019, CONTINUOUS NHANES PU, P2022
  • [2] Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement - Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study
    Anwaruddin, S
    Lloyd-Jones, DM
    Baggish, A
    Chen, A
    Krauser, D
    Tung, R
    Chae, C
    Januzzi, JL
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (01) : 91 - 97
  • [3] N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease - The African American Study of Kidney Disease and Hypertension (AASK)
    Astor, B. C.
    Yi, S.
    Hiremath, L.
    Corbin, T.
    Pogue, V.
    Wilkening, B.
    Peterson, G.
    Lewis, J.
    Lash, J. P.
    Van Lente, F.
    Gassman, J.
    Wang, X.
    Bakris, G.
    Appel, L. J.
    Contreras, G.
    [J]. CIRCULATION, 2008, 117 (13) : 1685 - 1692
  • [4] Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney disease
    Austin, Wendy J.
    Bhalla, Vikas
    Hernandez-Arce, Israel
    Isakson, Susan R.
    Beede, Jennifer
    Clopton, Paul
    Maisel, Alan S.
    Fitzgerald, Robert L.
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2006, 126 (04) : 506 - 512
  • [5] Bergmann MM, 1998, AM J EPIDEMIOL, V147, P969
  • [6] N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease
    Bibbins-Domingo, Kirsten
    Gupta, Reena
    Na, Beeya
    Wu, Alan H. B.
    Schiller, Nelson B.
    Whooley, Mary A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (02): : 169 - 176
  • [7] Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic peptide in patients with heart failure with versus without chronic kidney disease
    Bruch, Christian
    Fischer, Claudia
    Sindermann, Juergen
    Stypmann, Joerg
    Breithardt, Guenter
    Gradaus, Rainer
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (04) : 469 - 474
  • [8] Accuracy of Self-Reported Heart Failure. The Atherosclerosis Risk in Communities (ARIC) Study
    Camplain, Ricky
    Kucharska-Newton, Anna
    Loehr, Laura
    Keyserling, Thomas C.
    Layton, J. Bradley
    Wruck, Lisa
    Folsom, Aaron R.
    Bertoni, Alain G.
    Heiss, Gerardo
    [J]. JOURNAL OF CARDIAC FAILURE, 2017, 23 (11) : 802 - 808
  • [9] Interpreting Cardiac Biomarkers in the Setting of Chronic Kidney Disease
    deFilippi, Christopher R.
    Herzog, Charles A.
    [J]. CLINICAL CHEMISTRY, 2017, 63 (01) : 59 - 65
  • [10] FDA, Alinity i Total 8-hCG Reagent Kit